{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T14:45:53Z","timestamp":1788792353504,"version":"build-2803163510"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:00:00Z","timestamp":1768867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"vor","delay-in-days":22,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Cooperative Research Program of the Rural Development Administration","award":["RS-2022-RD010239"],"award-info":[{"award-number":["RS-2022-RD010239"]}]},{"name":"Grant from the Korea Institute of Oriental Medicine","award":["KSN2225021"],"award-info":[{"award-number":["KSN2225021"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-36728-3","type":"journal-article","created":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T10:24:20Z","timestamp":1768904660000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Soluble epoxide hydrolase inhibitory constituents from the Heartwood of Toxicodendron vernicifluum: isolation, kinetic characterization, molecular modeling, and quantitative analysis"],"prefix":"10.1038","volume":"16","author":[{"given":"Jang Hoon","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Young","family":"Cheon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Goo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Yeon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyong-Hwan","family":"Bang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Tae","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun-Ju","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ik Soo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,20]]},"reference":[{"key":"36728_CR1","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.pharmthera.2017.06.006","volume":"180","author":"KM Wagner","year":"2017","unstructured":"Wagner, K. M., McReynolds, C. B., Schmidt, W. K. & Hammock, B. D. Soluble epoxide hydrolase as a therapeutic target for pain, inflammatory and neurodegenerative diseases. Pharmacol. Ther. 180, 62\u201376 (2017).","journal-title":"Pharmacol. Ther."},{"key":"36728_CR2","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.plipres.2013.11.003","volume":"53","author":"G Zhang","year":"2014","unstructured":"Zhang, G., Kodani, S. & Hammock, B. D. Stabilized epoxygenated fatty acids regulate inflammation, pain, angiogenesis and cancer. Prog Lipid Res. 53, 108\u2013123 (2014).","journal-title":"Prog Lipid Res."},{"key":"36728_CR3","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.pneurobio.2018.11.001","volume":"172","author":"S Zarriello","year":"2019","unstructured":"Zarriello, S. et al. Humble beginnings with big goals: small molecule soluble epoxide hydrolase inhibitors for treating CNS disorders. Prog Neurobiol. 172, 23\u201339 (2019).","journal-title":"Prog Neurobiol."},{"key":"36728_CR4","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1021\/acs.jmedchem.0c01507","volume":"64","author":"CP Sun","year":"2021","unstructured":"Sun, C. P. et al. Discovery of soluble epoxide hydrolase inhibitors from chemical synthesis and natural products. J. Med. Chem. 64, 184\u2013215 (2021).","journal-title":"J. Med. Chem."},{"key":"36728_CR5","doi-asserted-by":"publisher","first-page":"179","DOI":"10.2217\/14796708.4.2.179","volume":"4","author":"JJ Iliff","year":"2009","unstructured":"Iliff, J. J. & Alkayed, N. J. Soluble epoxide hydrolase inhibition: targeting multiple mechanisms of ischemic brain injury with a single agent. Future Neurol. 4, 179\u2013199 (2009).","journal-title":"Future Neurol."},{"key":"36728_CR6","doi-asserted-by":"publisher","first-page":"e70033","DOI":"10.1111\/cts.70033","volume":"17","author":"WK Schmidt","year":"2024","unstructured":"Schmidt, W. K. et al. Randomized, double-blind, phase 1a single-ascending dose and food effect studies assessing safety and pharmacokinetics of EC5026 in healthy volunteers. Clin. Transl Sci. 17, e70033 (2024).","journal-title":"Clin. Transl Sci."},{"key":"36728_CR7","doi-asserted-by":"publisher","first-page":"3695","DOI":"10.3390\/foods11223695","volume":"11","author":"J Dang","year":"2022","unstructured":"Dang, J., Du, S. & Wang, L. Screening and identification of novel soluble epoxide hydrolase inhibitors from corn gluten peptides. Foods 11, 3695 (2022).","journal-title":"Foods"},{"key":"36728_CR8","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.jep.2016.09.044","volume":"194","author":"JY Liu","year":"2016","unstructured":"Liu, J. Y., Morisseau, C., Huang, H. & Hammock, B. D. Screening of soluble epoxide hydrolase inhibitory ingredients from traditional Chinese medicines for anti-inflammatory use. J. Ethnopharmacol. 194, 475\u2013482 (2016).","journal-title":"J. Ethnopharmacol."},{"key":"36728_CR9","first-page":"225","volume":"29","author":"H Dong","year":"2009","unstructured":"Dong, H., Wang, C., Gong, K. & Zhang, F. Advances in the research on the chemical constituents and comprehensive utilization of Rhus verniciflua Stokes. Chem. Ind. Prod. 29, 225\u2013232 (2009).","journal-title":"Chem. Ind. Prod."},{"key":"36728_CR10","doi-asserted-by":"publisher","first-page":"113476","DOI":"10.1016\/j.jep.2020.113476","volume":"267","author":"MC Li","year":"2021","unstructured":"Li, M. C. et al. Traditional uses, phytochemistry, and Pharmacology of toxicodendron vernicifluum (Stokes) F.A. Barkley - A review. J. Ethnopharmacol. 267, 113476 (2021).","journal-title":"J. Ethnopharmacol."},{"key":"36728_CR11","doi-asserted-by":"publisher","first-page":"104017","DOI":"10.1016\/j.bse.2020.104017","volume":"90","author":"MC Li","year":"2020","unstructured":"Li, M. C. et al. Chemical constituents from the Heartwood of toxicodendron vernicifluum (Stokes) FA Barkley. Biochem. Syst. Ecol. 90, 104017 (2020).","journal-title":"Biochem. Syst. Ecol."},{"key":"36728_CR12","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.ijbiomac.2018.02.061","volume":"112","author":"JH Kim","year":"2018","unstructured":"Kim, J. H. et al. In vitro and in Silico investigation of anthocyanin derivatives as soluble epoxide hydrolase inhibitors. Int. J. Biol. Macromol. 112, 961\u2013967 (2018).","journal-title":"Int. J. Biol. Macromol."},{"key":"36728_CR13","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1080\/14756366.2016.1189421","volume":"31","author":"AR Jo","year":"2016","unstructured":"Jo, A. R., Kim, J. H., Yan, X. T., Yang, S. Y. & Kim, Y. H. Soluble epoxide hydrolase inhibitory components from rheum undulatum and in Silico approach. J. Enzyme Inhib. Med. Chem. 31, 70\u201378 (2016).","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"36728_CR14","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1002\/bkcs.10068","volume":"36","author":"JH Kim","year":"2015","unstructured":"Kim, J. H. et al. Soluble epoxide hydrolase inhibitory constituents from selaginella Tamariscina. Bull. Korean Chem. Soc. 36, 300\u2013304 (2015).","journal-title":"Bull. Korean Chem. Soc."},{"key":"36728_CR15","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1007\/s10086-013-1385-8","volume":"60","author":"K Hashida","year":"2014","unstructured":"Hashida, K. et al. Phenolic extractives in the trunk of toxicodendron vernicifluum: chemical characteristics, contents and radial distribution. J. Wood Sci. 60, 160\u2013168 (2014).","journal-title":"J. Wood Sci."},{"key":"36728_CR16","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1016\/j.fct.2012.03.052","volume":"50","author":"N Cho","year":"2012","unstructured":"Cho, N. et al. Neuroprotective and anti-inflammatory effects of flavonoids isolated from Rhus verniciflua in neuronal HT22 and microglial BV2 cell lines. Food Chem. Toxicol. 50, 1940\u20131945 (2012).","journal-title":"Food Chem. Toxicol."},{"key":"36728_CR17","first-page":"759","volume":"11","author":"H Chen","year":"2016","unstructured":"Chen, H., Wang, C., Ye, J., Zhou, H. & Tao, R. Isolation of Sulfuretin and butin from Rhus verniciflua Stokes using Medium-pressure liquid chromatography and their tyrosinase inhibitory effects. BioResources 11, 759\u2013771 (2016).","journal-title":"BioResources"},{"key":"36728_CR18","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1248\/bpb.31.1626","volume":"31","author":"EH Lee","year":"2008","unstructured":"Lee, E. H. et al. Inhibitory effect of the compounds isolated from Rhus verniciflua on aldose reductase and advanced glycation endproducts. Biol. Pharm. Bull. 31, 1626\u20131630 (2008).","journal-title":"Biol. Pharm. Bull."},{"key":"36728_CR19","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.53730\/ijhs.v6nS8.12333","volume":"6","author":"G Balaji","year":"2022","unstructured":"Balaji, G., Sangaraju, R., Sinha, S. N. & Shashikala, P. Identification and characterization of Ethyl gallate from Ethyl acetate fraction of phyllanthus emblica fruit, and invitro free radical scavenging activity. Int. J. Health Sci. 6, 2390\u20132400 (2022).","journal-title":"Int. J. Health Sci."},{"key":"36728_CR20","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1007\/s00217-007-0653-5","volume":"226","author":"Z He","year":"2008","unstructured":"He, Z., Xia, W. & Chen, J. Isolation and structure Elucidation of phenolic compounds in Chinese Olive (Canarium album L.) fruit. Eur. Food Res. Technol. 226, 1191\u20131196 (2008).","journal-title":"Eur. Food Res. Technol."},{"key":"36728_CR21","doi-asserted-by":"publisher","first-page":"108997","DOI":"10.1016\/j.bioorg.2025.108997","volume":"165","author":"K \u00c7al\u0131\u015fkan","year":"2025","unstructured":"\u00c7al\u0131\u015fkan, K. et al. Harnessing structure-activity relationships to repurpose the FLAP inhibitor BRP-7 into potent and selective sEH inhibitors. Bioorg. Chem. 165, 108997 (2025).","journal-title":"Bioorg. Chem."},{"key":"36728_CR22","doi-asserted-by":"crossref","unstructured":"Argiriadi, M. A., Morisseau, C., Hammock, B. D. & Christianson, D. W. Detoxification of environmental mutagens and carcinogens: Structure, mechanism, and evolution of liver epoxide hydrolase. Proc. Natl. Acad. Sci. U. S. A. 96, 10637\u201310642 (1999).","DOI":"10.1073\/pnas.96.19.10637"},{"key":"36728_CR23","doi-asserted-by":"publisher","first-page":"15265","DOI":"10.1074\/jbc.M000278200","volume":"275","author":"MA Argiriadi","year":"2000","unstructured":"Argiriadi, M. A. et al. Binding of alkylurea inhibitors to epoxide hydrolase implicates active site tyrosines in substrate activation. J. Biol. Chem. 275, 15265\u201315270 (2000).","journal-title":"J. Biol. Chem."},{"key":"36728_CR24","doi-asserted-by":"publisher","first-page":"e2410011","DOI":"10.4014\/jmb.2410.10011","volume":"35","author":"JH Kim","year":"2024","unstructured":"Kim, J. H. et al. Inhibitory activity of glycosides from Elsholtzia ciliata against soluble epoxide hydrolase and cytokines in RAW264.7 cells. J. Microbiol. Biotechnol. 35, e2410011 (2024).","journal-title":"J. Microbiol. Biotechnol."},{"key":"36728_CR25","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3389\/fphar.2019.00036","volume":"10","author":"K Hashimoto","year":"2019","unstructured":"Hashimoto, K. Role of soluble epoxide hydrolase in metabolism of PUFAs in psychiatric and neurological disorders. Front. Pharmacol. 10, 36 (2019).","journal-title":"Front. Pharmacol."},{"key":"36728_CR26","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.bbrc.2010.08.014","volume":"400","author":"MY Song","year":"2010","unstructured":"Song, M. Y. et al. Sulfuretin attenuates allergic airway inflammation in mice. Biochem. Biophys. Res. Commun. 400, 83\u201388 (2010).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"36728_CR27","doi-asserted-by":"publisher","first-page":"2894","DOI":"10.1111\/bph.13569","volume":"173","author":"DS Lee","year":"2016","unstructured":"Lee, D. S. & Jeong, G. S. Butein provides neuroprotective and anti-neuroinflammatory effects through Nrf2\/ARE-dependent haem Oxygenase 1 expression by activating the PI3K\/Akt pathway. Br. J. Pharmacol. 173, 2894\u20132909 (2016).","journal-title":"Br. J. Pharmacol."},{"key":"36728_CR28","doi-asserted-by":"publisher","first-page":"3724","DOI":"10.3390\/ijms25073724","volume":"25","author":"H Liu","year":"2024","unstructured":"Liu, H. & Lu, Q. Fisetin alleviates inflammation and oxidative stress in deep vein thrombosis via MAPK and NRF2 signaling pathway. Int. J. Mol. Sci. 25, 3724 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"36728_CR29","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1089\/jmf.2013.3116","volume":"18","author":"JH Lee","year":"2014","unstructured":"Lee, J. H. et al. Antiplatelet effects of Rhus verniciflua Stokes Heartwood and its active Constituents\u2014Fisetin, Butein, and Sulfuretin\u2014in rats. J. Med. Food. 18, 21\u201330 (2014).","journal-title":"J. Med. Food"},{"key":"36728_CR30","doi-asserted-by":"publisher","first-page":"7016","DOI":"10.1021\/jm500694p","volume":"57","author":"KS Lee","year":"2014","unstructured":"Lee, K. S. et al. Optimized inhibitors of soluble epoxide hydrolase improve in vitro target residence time and in vivo efficacy. J. Med. Chem. 57, 7016\u20137030 (2014).","journal-title":"J. Med. Chem."},{"key":"36728_CR31","doi-asserted-by":"publisher","first-page":"104512","DOI":"10.1016\/j.isci.2022.104512","volume":"25","author":"G Bai","year":"2022","unstructured":"Bai, G. et al. The chromosome-level genome for toxicodendron vernicifluum provides crucial insights into anacardiaceae evolution and Urushiol biosynthesis. iScience 25, 104512 (2022).","journal-title":"iScience"},{"key":"36728_CR32","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.3390\/pharmaceutics14051045","volume":"14","author":"L G\u00f3mez-Segura","year":"2022","unstructured":"G\u00f3mez-Segura, L. et al. Swine as the animal model for testing new formulations of Anti-Inflammatory drugs: carprofen pharmacokinetics and bioavailability of the intramuscular route. Pharmaceutics 14, 1045 (2022).","journal-title":"Pharmaceutics"},{"key":"36728_CR33","doi-asserted-by":"publisher","first-page":"3439","DOI":"10.1021\/acsptsci.4c00068","volume":"7","author":"S Risen","year":"2024","unstructured":"Risen, S. et al. Large- and Small-Animal studies of Safety, Pharmacokinetics, and biodistribution of Inflammasome-Targeting nanoligomer in the brain and other target organs. ACS Pharmacol. Transl Sci. 7, 3439\u20133451 (2024).","journal-title":"ACS Pharmacol. Transl Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36728-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36728-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36728-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T09:15:20Z","timestamp":1770801320000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36728-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,20]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["36728"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-36728-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8274523\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,20]]},"assertion":[{"value":"4 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5800"}}